v3.26.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2026
Sep. 30, 2025
Current assets    
Allowance for credit losses on Accounts receivables $ 4 $ 2
Noncurrent assets    
Allowance for credit losses on Asbestos insurance receivable $ 2 $ 2
Stockholders' Equity    
Common stock, shares authorized 200,000,000 200,000,000
Common stock, par value per share (usd per share) $ 0.01 $ 0.01
Common stock, shares issued 46,000,000 46,000,000